Latest financial market updates and expert analysis
Analysis Roche has reported a significant milestone in its drug development pipeline, with its candidate Fenebrutinib delivering strong results in a major late-stage clinical trial for multiple sclerosis. This success raises...
Rocket Lab USA announced its strongest financial performance to date, yet investor focus was captured by a significant schedule revision...
Investors in silver are navigating a period of significant volatility. The iShares Silver Trust, a popular exchange-traded fund offering exposure...
Investors in additive manufacturing specialist 3D Systems are awaiting a key corporate event scheduled for Monday, March 9, 2026. On...
Navigating a landscape of shifting consumer preferences, Church & Dwight remains focused on a core strategic question: how to efficiently...
The current macroeconomic landscape is prompting a significant reassessment of global equity allocations. Investors in funds like the Vanguard Total...
Jaguar Health has bolstered its financial position with a $3 million payment received this Tuesday from its licensing partner, Future...
Investors holding CHS Inc.’s Series 4 preferred stock have two significant events on their calendar for March. With a lack...
Technology stocks are navigating a complex landscape of macroeconomic pressures and technical deterioration. Within this challenging environment, Trio-Tech International finds...
Currently trading in close alignment with broader market indices, Rogers’ stock is experiencing a period driven more by macroeconomic forces...
Spruce Biosciences Inc has announced a revised schedule for its regulatory submission of TA-ERT, a potential treatment for Sanfilippo syndrome...
